What Is Patent Valuation? A Plain Definition for Owners

What is patent valuation? It is an estimate of how much money a specific patent right is worth, for a stated purpose, to a stated party, on a stated date. Take away any one of those four and you do not have a valuation. You have a guess with a currency sign in front of it.

That is not our wording alone. A certified appraiser defines intellectual property valuation as estimating the value of specific intangible legal rights under a defined purpose, standard of value, premise of value, and valuation date. The German standard goes further. Under DIN 77100, a patent per se cannot be valued; only a patent used in a concrete exploitation scenario can be assessed, and patent value is the expected future financial benefit from that exploitation, measured at the valuation date.

Read that twice, because it changes the question. "What is my patent worth?" has no answer. "What is this patent worth to this buyer, for this deal, today?" does.

This article stays on the definition: the five things every valuation has to state, the reasons people commission one, and what a valuation is not. If you already know that and want the mechanics, go straight to the patent valuation methods.

The five things every patent valuation has to state

DIN 77100 is useful here even outside Germany, because it names the building blocks plainly. The standard defines the valuation object and reason, the underlying utilization scenario, the valuation date and the expert evaluator. Add the standard of value, which sits inside the scenario, and you have a checklist you can hold any report against.

1. The object: which rights, exactly

Not "the invention". The claims as granted or as filed, in which territories, with how many years of term left, owned by whom. A family with a granted US patent and a pending European application is two different objects with two different risk profiles. A valuation that does not say which one it priced has not told you anything.

The object also excludes things. DIN 77100 insists that the value of the patent be separated from the value of the complementary goods needed to exploit it: the factory, the brand, the distribution. A patent that only earns money inside one company's supply chain is worth less on its own than the product it protects.

2. The purpose: who asked, and why

Purpose is not a formality. The World Intellectual Property Organization puts it bluntly: the purpose defines the legal or regulatory statutes, the court of resolution, the acceptable methodologies and the rules of thumb that apply. An auditor, a judge and a buyer are asking different questions, and each has its own rulebook for what counts as an answer.

3. The scenario and the standard of value

This is where most confusion lives. The same patent can be valued at fair value, fair market value or investment value, and each context may produce a different value for the same patent because the premise of value differs, not because anyone got the maths wrong.

A market value asks what a hypothetical buyer would pay at arm's length, ignoring owner specific synergies. An investment value asks what the asset is worth to one particular party. Those can sit far apart. As one consulting team notes, a buyer with a complementary product line may see far greater commercial synergies than the current owner, while an acquirer without manufacturing or distribution may attribute less value even to a robust family.

Think of it like a building. The surveyor's number for the bank, the insurer's rebuild figure and the price the neighbour would pay to knock through a wall are all "the value". None of them is wrong. They answer different questions.

4. The valuation date

Patents are wasting assets. Every month of term that passes is a month of exclusivity nobody can buy back, and every new piece of prior art, court ruling or competing product moves the number. A valuation is a photograph, not a certificate. One dated eighteen months ago describes a different asset.

5. The evaluator

Who signs matters. DIN 77100 sets requirements for expert valuators and guidelines for valuation reports, and asks that every valuation criterion be transparent and understandable to non-experts. That transparency is the practical test: if you cannot trace the headline figure back to stated assumptions, you cannot defend it in a negotiation, an audit or a courtroom.

Why people commission a patent valuation

There are dozens of reasons. Six account for most of the work:

• Sale or licence. Here the output is usually a go or no go: at what price am I willing to enter this transaction? That is how WIPO frames transaction strategy, and it is the purpose closest to a real market.
• Financial reporting. Acquired patents have to be carried on the balance sheet. In the US this followed the FASB rules for acquired intangibles introduced in 2001; internationally it runs under IFRS 3 acquisition accounting.
• Litigation. Damages in an infringement case: lost profits, a reasonable royalty, apportionment. These values are tied to one infringement scenario and nothing else.
• Tax and transfer pricing. Moving IP between connected companies needs an arm's length figure, or an arm's length royalty for a licence.
• Financing. Patents can back a loan. The robustness a lender needs depends on how significant the asset is and what it is securing.
• Insolvency. In a restructuring the patents are often among the few assets left with value, and someone has to put a number on them.

The resulting figures can differ dramatically, even for the same patent portfolio, and accounting valuations tend to be the more conservative.

For owners in Germany there is a seventh reason that barely exists elsewhere. DIN 77100 was written to supplement existing rules including accounting and the Arbeitnehmererfinderrecht, the German Employee Invention Act, so a patent valuation there can be as much an employment question as a deal question.

Why one patent can carry three different numbers

Picture one patent family valued three times in the same year. For the auditor after an acquisition, it is fair value under strict accounting rules. For a licensing negotiation, it is what a willing licensee would pay in royalties. For a lawsuit, it is the damage one named infringer caused. Three numbers, one asset, no contradiction.

What the definition does not promise is that any of those numbers is large. Value in patents is concentrated. One analysis of 9,000 patents found only 7.2 percent were worth over 10 million euro and 68 percent were below 1 million euro. On a pure market basis the picture is harsher still: a broker with thousands of transactions on the record puts the value of roughly 99 percent of issued patents at zero, because no acquirer wants to take on the annuity costs of an asset nobody is using.

That is not a reason to skip valuation. It is a reason to be precise about which question you are paying someone to answer.

What a patent valuation is not

• It is not a price. A price needs a counterparty, a date and a signature. We have written separately on why the valuation number is not the price.
• It is not a legal opinion. Ownership, validity and enforceability are for patent counsel. The valuer connects those legal facts to cash flows and risk; they do not decide them.
• It is not your filing cost. What you spent on attorneys and official fees says nothing about economic benefit. A cheap patent can protect a large market and an expensive one can protect nothing.
• It is not a balance sheet entry. Legal ownership, accounting recognition and appraisal value are three separate things. An internally developed patent can be valuable without ever appearing at fair value in the accounts.
• It is not a grant. A pending application can be valued, but it is a different object. The claims may narrow or be refused, and an honest valuation prices that risk instead of treating the application as if it were already a granted patent.

Where EX IX sits in this

We are brokers, so we see valuation from the end of the pipe where a buyer either signs or does not. That shapes two things we do.

First, we test the asset before it meets a buyer. Our validation gate uses physics-grade claim reconstruction, detectability analysis and validity probability, benchmarked at 0.76 percent mean absolute percentage error against real-world outcomes. Detectability sounds technical, but it goes straight to the definition above: if you cannot show a claim is being practised, there is no exploitation scenario, and under DIN 77100 there is nothing to value.

Second, we are paid for outcomes, not for numbers. Our brokerage is success based: the seller pays commission on completion, with a minimum fee of EUR 5,000 per completed transaction, and no sale means no fee. A report paid for up front gets paid whether the asset sells or not. We only get paid if it does, which is why we care more about the buyer's number than the model's.

If you are about to commission a valuation, do the free groundwork first: here is how to value a patent yourself before paying for a report, and here is what patents actually sell for once a buyer is in the room.

FAQ

Is there an official standard for patent valuation?

Yes. In Germany, DIN 77100, published in 2011, sets general principles for monetary patent valuation. It ranks methods by how much reliable information is available and prefers the income approach, mainly excess earnings and licence analogy. It deliberately gives no step by step instructions, so two compliant valuations can still differ.

How long is a patent valuation valid?

Only as of its valuation date. There is no fixed shelf life, but any material change resets it: a grant or refusal, a new competitor, a court ruling on similar claims, or simply years of term running out. For a transaction, a valuation more than a year old should be refreshed.

Can a patent valuation be done for free?

A formal, signed report cannot, because someone has to take professional responsibility for the assumptions. A first triage can: checking remaining term, territory, claim scope and whether anyone is practising the claims costs time rather than money, and it often tells you whether a paid report is worth ordering at all.

Do patents help with getting a loan?

They can. One study reported credit approvals of 54 percent with patents against 46 percent without. A lender will still want a valuation built for security purposes, which usually means a conservative market value rather than the owner's view.